Green Thumb Industries Inc GTII

Morningstar Rating
CA$9.55 −0.17 (1.75%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

GTII is trading at a LOCK|xdVqC< premium.
Price
CA$9.72
Fair Value
LOCK|.^&z&&d
Uncertainty
LOCK|fCw
1-Star Price
LOCK|.tkXkrj
5-Star Price
LOCK|.?^>^!C
Economic Moat
LOCK|v<
Capital Allocation
LOCK|t<f$^JB

Trading Information

Previous Close Price
CA$9.72
Day Range
CA$9.40–9.77
52-Week Range
CA$7.40–14.39
Bid/Ask
CA$9.40 / CA$9.65
Shares Outstanding
218.59M
Market Cap
CA$2.09B
Volume/Avg
160,351 / 127,258

Key Statistics

Price/Earnings (Normalized)
95.12
Price/Sales
1.35
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Dividend Payment Schedule
—
Total Yield
6.22%

Company Profile

Green Thumb Industries is headquartered in Chicago, Illinois, and produces and sells medicinal and recreational cannabis through wholesale and retail channels in the United States. It has a presence in 14 states and operates more than 100 cannabis stores under the brand Rise. GTI is focusing its expansion on limited-license states with large populations, and it does not currently export into the global medical market due to the USA federal prohibition. It offers multiple products under a portfolio of cannabis consumer packaged goods brands, including &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, Incredibles, and RYTHM.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees
5,000

Valuation

Metric
GTII
Price/Earnings (Normalized)
95.12
Price/Book Value
0.80
Price/Sales
1.35
Price/Cash Flow
4.45
Price/Earnings
GTII

Financial Strength

Metric
GTII
Quick Ratio
1.87
Current Ratio
2.85
Interest Coverage
13.36
Quick Ratio
GTII

Profitability

Metric
GTII
Return on Assets (Normalized)
−4.20%
Return on Equity (Normalized)
−6.16%
Return on Invested Capital (Normalized)
−4.59%
Return on Assets
GTII

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Merck KGaA ADR
MKKGY
LOCK|C#&$%L!LOCK|&#Bd$66B
Teva Pharmaceutical Industries Ltd
TEVA
LOCK|>S&Spv%#LOCK|#%QdS$46B
Haleon PLC ADR
HLN
LOCK|d>bcp?LOCK|Mp$38B
Zoetis Inc Class A
ZTS
LOCK|FH%r@TK#LOCK|$kh$29B
Viatris Inc
VTRS
LOCK|p$^H%FLOCK|vs$20B
Elanco Animal Health Inc
ELAN
LOCK|<Y&LOCK|>Q^$11B
Dr Reddy's Laboratories Ltd ADR
RDY
LOCK|TP&V?pLOCK|WD?$10B
Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
LOCK|@TTzh#YLOCK|&V$7B
Prestige Consumer Healthcare Inc
PBH
LOCK|jCX>$?WLOCK|?NPKf$2B
Perrigo Co PLC
PRGO
LOCK|bZW?^&LOCK|YQ!$2B

Sponsor Center